Analysis of large Danish and American datasets suggests that poor air quality may increase the prevalence of neurological and psychiatric disorders.
Browsing: psychiatric disorders
Researchers have identified that the N-terminal fragment of galanin is involved in promoting anhedonia and could therefore be a potential therapeutic target for the treatment of depression.
Scientists have demonstrated how variations in a gene linked to anxiety and depression could affect a patient’s response to treatment.
The link between emotional processing and our immune responses – as seen in the placebo effect – could lead to new avenues for treating psychiatric diseases, according to research.
Study also finds that information predictive of major depressive disorder is distributed across brain networks, rather than being highly localized.
Study indicates deep brain stimulation can alleviate the long-term symptoms for patients suffering from treatment-resistant depression.
New research describes how eugeroic drug modafinil may improve the memory of individuals recovering from depression.
Evaluation of over 10 million insurance claims in the USA provides evidence of “adverse selection” in the prescription of opioids.
An introduction to mental health, its prevalence in England and Mind’s thoughts about NHS Digital’s Adult Psychiatric Morbidity Survey.